Global Dry Age-Related Macular Degeneration Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 103
Published Date: 04 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Dry Age-Related Macular Degeneration market size was valued at USD 1426.1 million in 2023 and is forecast to a readjusted size of USD 2175.8 million by 2030 with a CAGR of 6.2% during review period.
Dry macular degeneration is a common eye disorder among people over 50. It causes blurred or reduced central vision, due to thinning of the macula (MAK-u-luh). The macula is the part of the retina responsible for clear vision in your direct line of sight.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Dry Age-Related Macular Degeneration industry chain, the market status of Above 40 Years (Oral, Injectables), Above 60 Years (Oral, Injectables), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Dry Age-Related Macular Degeneration.
Regionally, the report analyzes the Dry Age-Related Macular Degeneration markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Dry Age-Related Macular Degeneration market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Dry Age-Related Macular Degeneration market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Dry Age-Related Macular Degeneration industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Oral, Injectables).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Dry Age-Related Macular Degeneration market.
Regional Analysis: The report involves examining the Dry Age-Related Macular Degeneration market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Dry Age-Related Macular Degeneration market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Dry Age-Related Macular Degeneration:
Company Analysis: Report covers individual Dry Age-Related Macular Degeneration players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Dry Age-Related Macular Degeneration This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Above 40 Years, Above 60 Years).
Technology Analysis: Report covers specific technologies relevant to Dry Age-Related Macular Degeneration. It assesses the current state, advancements, and potential future developments in Dry Age-Related Macular Degeneration areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Dry Age-Related Macular Degeneration market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Dry Age-Related Macular Degeneration market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Oral
Injectables
Market segment by Application
Above 40 Years
Above 60 Years
Above 75 Years
Market segment by players, this report covers
Santen Pharmaceuticals
Allergan
Bausch Health
Alimera Science
Phio Pharmaceuticals
Ocumension Therapeutics
Belite Bio
Kubota Vision
Iveric Bio
Eyestem Research
Y2 Solution
Stealth Biotherapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Dry Age-Related Macular Degeneration product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Dry Age-Related Macular Degeneration, with revenue, gross margin and global market share of Dry Age-Related Macular Degeneration from 2019 to 2024.
Chapter 3, the Dry Age-Related Macular Degeneration competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Dry Age-Related Macular Degeneration market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Dry Age-Related Macular Degeneration.
Chapter 13, to describe Dry Age-Related Macular Degeneration research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Dry Age-Related Macular Degeneration
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Dry Age-Related Macular Degeneration by Type
1.3.1 Overview: Global Dry Age-Related Macular Degeneration Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Dry Age-Related Macular Degeneration Consumption Value Market Share by Type in 2023
1.3.3 Oral
1.3.4 Injectables
1.4 Global Dry Age-Related Macular Degeneration Market by Application
1.4.1 Overview: Global Dry Age-Related Macular Degeneration Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Above 40 Years
1.4.3 Above 60 Years
1.4.4 Above 75 Years
1.5 Global Dry Age-Related Macular Degeneration Market Size & Forecast
1.6 Global Dry Age-Related Macular Degeneration Market Size and Forecast by Region
1.6.1 Global Dry Age-Related Macular Degeneration Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Dry Age-Related Macular Degeneration Market Size by Region, (2019-2030)
1.6.3 North America Dry Age-Related Macular Degeneration Market Size and Prospect (2019-2030)
1.6.4 Europe Dry Age-Related Macular Degeneration Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Dry Age-Related Macular Degeneration Market Size and Prospect (2019-2030)
1.6.6 South America Dry Age-Related Macular Degeneration Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Dry Age-Related Macular Degeneration Market Size and Prospect (2019-2030)
2.1 Santen Pharmaceuticals
2.1.1 Santen Pharmaceuticals Details
2.1.2 Santen Pharmaceuticals Major Business
2.1.3 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product and Solutions
2.1.4 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Santen Pharmaceuticals Recent Developments and Future Plans
2.2 Allergan
2.2.1 Allergan Details
2.2.2 Allergan Major Business
2.2.3 Allergan Dry Age-Related Macular Degeneration Product and Solutions
2.2.4 Allergan Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Allergan Recent Developments and Future Plans
2.3 Bausch Health
2.3.1 Bausch Health Details
2.3.2 Bausch Health Major Business
2.3.3 Bausch Health Dry Age-Related Macular Degeneration Product and Solutions
2.3.4 Bausch Health Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bausch Health Recent Developments and Future Plans
2.4 Alimera Science
2.4.1 Alimera Science Details
2.4.2 Alimera Science Major Business
2.4.3 Alimera Science Dry Age-Related Macular Degeneration Product and Solutions
2.4.4 Alimera Science Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Alimera Science Recent Developments and Future Plans
2.5 Phio Pharmaceuticals
2.5.1 Phio Pharmaceuticals Details
2.5.2 Phio Pharmaceuticals Major Business
2.5.3 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product and Solutions
2.5.4 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Phio Pharmaceuticals Recent Developments and Future Plans
2.6 Ocumension Therapeutics
2.6.1 Ocumension Therapeutics Details
2.6.2 Ocumension Therapeutics Major Business
2.6.3 Ocumension Therapeutics Dry Age-Related Macular Degeneration Product and Solutions
2.6.4 Ocumension Therapeutics Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Ocumension Therapeutics Recent Developments and Future Plans
2.7 Belite Bio
2.7.1 Belite Bio Details
2.7.2 Belite Bio Major Business
2.7.3 Belite Bio Dry Age-Related Macular Degeneration Product and Solutions
2.7.4 Belite Bio Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Belite Bio Recent Developments and Future Plans
2.8 Kubota Vision
2.8.1 Kubota Vision Details
2.8.2 Kubota Vision Major Business
2.8.3 Kubota Vision Dry Age-Related Macular Degeneration Product and Solutions
2.8.4 Kubota Vision Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Kubota Vision Recent Developments and Future Plans
2.9 Iveric Bio
2.9.1 Iveric Bio Details
2.9.2 Iveric Bio Major Business
2.9.3 Iveric Bio Dry Age-Related Macular Degeneration Product and Solutions
2.9.4 Iveric Bio Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Iveric Bio Recent Developments and Future Plans
2.10 Eyestem Research
2.10.1 Eyestem Research Details
2.10.2 Eyestem Research Major Business
2.10.3 Eyestem Research Dry Age-Related Macular Degeneration Product and Solutions
2.10.4 Eyestem Research Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Eyestem Research Recent Developments and Future Plans
2.11 Y2 Solution
2.11.1 Y2 Solution Details
2.11.2 Y2 Solution Major Business
2.11.3 Y2 Solution Dry Age-Related Macular Degeneration Product and Solutions
2.11.4 Y2 Solution Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Y2 Solution Recent Developments and Future Plans
2.12 Stealth Biotherapeutics
2.12.1 Stealth Biotherapeutics Details
2.12.2 Stealth Biotherapeutics Major Business
2.12.3 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product and Solutions
2.12.4 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Stealth Biotherapeutics Recent Developments and Future Plans
3.1 Global Dry Age-Related Macular Degeneration Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Dry Age-Related Macular Degeneration by Company Revenue
3.2.2 Top 3 Dry Age-Related Macular Degeneration Players Market Share in 2023
3.2.3 Top 6 Dry Age-Related Macular Degeneration Players Market Share in 2023
3.3 Dry Age-Related Macular Degeneration Market: Overall Company Footprint Analysis
3.3.1 Dry Age-Related Macular Degeneration Market: Region Footprint
3.3.2 Dry Age-Related Macular Degeneration Market: Company Product Type Footprint
3.3.3 Dry Age-Related Macular Degeneration Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Dry Age-Related Macular Degeneration Consumption Value and Market Share by Type (2019-2024)
4.2 Global Dry Age-Related Macular Degeneration Market Forecast by Type (2025-2030)
5.1 Global Dry Age-Related Macular Degeneration Consumption Value Market Share by Application (2019-2024)
5.2 Global Dry Age-Related Macular Degeneration Market Forecast by Application (2025-2030)
6.1 North America Dry Age-Related Macular Degeneration Consumption Value by Type (2019-2030)
6.2 North America Dry Age-Related Macular Degeneration Consumption Value by Application (2019-2030)
6.3 North America Dry Age-Related Macular Degeneration Market Size by Country
6.3.1 North America Dry Age-Related Macular Degeneration Consumption Value by Country (2019-2030)
6.3.2 United States Dry Age-Related Macular Degeneration Market Size and Forecast (2019-2030)
6.3.3 Canada Dry Age-Related Macular Degeneration Market Size and Forecast (2019-2030)
6.3.4 Mexico Dry Age-Related Macular Degeneration Market Size and Forecast (2019-2030)
7.1 Europe Dry Age-Related Macular Degeneration Consumption Value by Type (2019-2030)
7.2 Europe Dry Age-Related Macular Degeneration Consumption Value by Application (2019-2030)
7.3 Europe Dry Age-Related Macular Degeneration Market Size by Country
7.3.1 Europe Dry Age-Related Macular Degeneration Consumption Value by Country (2019-2030)
7.3.2 Germany Dry Age-Related Macular Degeneration Market Size and Forecast (2019-2030)
7.3.3 France Dry Age-Related Macular Degeneration Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Dry Age-Related Macular Degeneration Market Size and Forecast (2019-2030)
7.3.5 Russia Dry Age-Related Macular Degeneration Market Size and Forecast (2019-2030)
7.3.6 Italy Dry Age-Related Macular Degeneration Market Size and Forecast (2019-2030)
8.1 Asia-Pacific Dry Age-Related Macular Degeneration Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Dry Age-Related Macular Degeneration Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Dry Age-Related Macular Degeneration Market Size by Region
8.3.1 Asia-Pacific Dry Age-Related Macular Degeneration Consumption Value by Region (2019-2030)
8.3.2 China Dry Age-Related Macular Degeneration Market Size and Forecast (2019-2030)
8.3.3 Japan Dry Age-Related Macular Degeneration Market Size and Forecast (2019-2030)
8.3.4 South Korea Dry Age-Related Macular Degeneration Market Size and Forecast (2019-2030)
8.3.5 India Dry Age-Related Macular Degeneration Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Dry Age-Related Macular Degeneration Market Size and Forecast (2019-2030)
8.3.7 Australia Dry Age-Related Macular Degeneration Market Size and Forecast (2019-2030)
9.1 South America Dry Age-Related Macular Degeneration Consumption Value by Type (2019-2030)
9.2 South America Dry Age-Related Macular Degeneration Consumption Value by Application (2019-2030)
9.3 South America Dry Age-Related Macular Degeneration Market Size by Country
9.3.1 South America Dry Age-Related Macular Degeneration Consumption Value by Country (2019-2030)
9.3.2 Brazil Dry Age-Related Macular Degeneration Market Size and Forecast (2019-2030)
9.3.3 Argentina Dry Age-Related Macular Degeneration Market Size and Forecast (2019-2030)
10.1 Middle East & Africa Dry Age-Related Macular Degeneration Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Dry Age-Related Macular Degeneration Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Dry Age-Related Macular Degeneration Market Size by Country
10.3.1 Middle East & Africa Dry Age-Related Macular Degeneration Consumption Value by Country (2019-2030)
10.3.2 Turkey Dry Age-Related Macular Degeneration Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Dry Age-Related Macular Degeneration Market Size and Forecast (2019-2030)
10.3.4 UAE Dry Age-Related Macular Degeneration Market Size and Forecast (2019-2030)
11.1 Dry Age-Related Macular Degeneration Market Drivers
11.2 Dry Age-Related Macular Degeneration Market Restraints
11.3 Dry Age-Related Macular Degeneration Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 Dry Age-Related Macular Degeneration Industry Chain
12.2 Dry Age-Related Macular Degeneration Upstream Analysis
12.3 Dry Age-Related Macular Degeneration Midstream Analysis
12.4 Dry Age-Related Macular Degeneration Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Dry Age-Related Macular Degeneration Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Dry Age-Related Macular Degeneration Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Dry Age-Related Macular Degeneration Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Dry Age-Related Macular Degeneration Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Santen Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 6. Santen Pharmaceuticals Major Business
Table 7. Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product and Solutions
Table 8. Santen Pharmaceuticals Dry Age-Related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Santen Pharmaceuticals Recent Developments and Future Plans
Table 10. Allergan Company Information, Head Office, and Major Competitors
Table 11. Allergan Major Business
Table 12. Allergan Dry Age-Related Macular Degeneration Product and Solutions
Table 13. Allergan Dry Age-Related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Allergan Recent Developments and Future Plans
Table 15. Bausch Health Company Information, Head Office, and Major Competitors
Table 16. Bausch Health Major Business
Table 17. Bausch Health Dry Age-Related Macular Degeneration Product and Solutions
Table 18. Bausch Health Dry Age-Related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Bausch Health Recent Developments and Future Plans
Table 20. Alimera Science Company Information, Head Office, and Major Competitors
Table 21. Alimera Science Major Business
Table 22. Alimera Science Dry Age-Related Macular Degeneration Product and Solutions
Table 23. Alimera Science Dry Age-Related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Alimera Science Recent Developments and Future Plans
Table 25. Phio Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 26. Phio Pharmaceuticals Major Business
Table 27. Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product and Solutions
Table 28. Phio Pharmaceuticals Dry Age-Related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Phio Pharmaceuticals Recent Developments and Future Plans
Table 30. Ocumension Therapeutics Company Information, Head Office, and Major Competitors
Table 31. Ocumension Therapeutics Major Business
Table 32. Ocumension Therapeutics Dry Age-Related Macular Degeneration Product and Solutions
Table 33. Ocumension Therapeutics Dry Age-Related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Ocumension Therapeutics Recent Developments and Future Plans
Table 35. Belite Bio Company Information, Head Office, and Major Competitors
Table 36. Belite Bio Major Business
Table 37. Belite Bio Dry Age-Related Macular Degeneration Product and Solutions
Table 38. Belite Bio Dry Age-Related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Belite Bio Recent Developments and Future Plans
Table 40. Kubota Vision Company Information, Head Office, and Major Competitors
Table 41. Kubota Vision Major Business
Table 42. Kubota Vision Dry Age-Related Macular Degeneration Product and Solutions
Table 43. Kubota Vision Dry Age-Related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Kubota Vision Recent Developments and Future Plans
Table 45. Iveric Bio Company Information, Head Office, and Major Competitors
Table 46. Iveric Bio Major Business
Table 47. Iveric Bio Dry Age-Related Macular Degeneration Product and Solutions
Table 48. Iveric Bio Dry Age-Related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Iveric Bio Recent Developments and Future Plans
Table 50. Eyestem Research Company Information, Head Office, and Major Competitors
Table 51. Eyestem Research Major Business
Table 52. Eyestem Research Dry Age-Related Macular Degeneration Product and Solutions
Table 53. Eyestem Research Dry Age-Related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Eyestem Research Recent Developments and Future Plans
Table 55. Y2 Solution Company Information, Head Office, and Major Competitors
Table 56. Y2 Solution Major Business
Table 57. Y2 Solution Dry Age-Related Macular Degeneration Product and Solutions
Table 58. Y2 Solution Dry Age-Related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Y2 Solution Recent Developments and Future Plans
Table 60. Stealth Biotherapeutics Company Information, Head Office, and Major Competitors
Table 61. Stealth Biotherapeutics Major Business
Table 62. Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product and Solutions
Table 63. Stealth Biotherapeutics Dry Age-Related Macular Degeneration Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Stealth Biotherapeutics Recent Developments and Future Plans
Table 65. Global Dry Age-Related Macular Degeneration Revenue (USD Million) by Players (2019-2024)
Table 66. Global Dry Age-Related Macular Degeneration Revenue Share by Players (2019-2024)
Table 67. Breakdown of Dry Age-Related Macular Degeneration by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Dry Age-Related Macular Degeneration, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 69. Head Office of Key Dry Age-Related Macular Degeneration Players
Table 70. Dry Age-Related Macular Degeneration Market: Company Product Type Footprint
Table 71. Dry Age-Related Macular Degeneration Market: Company Product Application Footprint
Table 72. Dry Age-Related Macular Degeneration New Market Entrants and Barriers to Market Entry
Table 73. Dry Age-Related Macular Degeneration Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Dry Age-Related Macular Degeneration Consumption Value (USD Million) by Type (2019-2024)
Table 75. Global Dry Age-Related Macular Degeneration Consumption Value Share by Type (2019-2024)
Table 76. Global Dry Age-Related Macular Degeneration Consumption Value Forecast by Type (2025-2030)
Table 77. Global Dry Age-Related Macular Degeneration Consumption Value by Application (2019-2024)
Table 78. Global Dry Age-Related Macular Degeneration Consumption Value Forecast by Application (2025-2030)
Table 79. North America Dry Age-Related Macular Degeneration Consumption Value by Type (2019-2024) & (USD Million)
Table 80. North America Dry Age-Related Macular Degeneration Consumption Value by Type (2025-2030) & (USD Million)
Table 81. North America Dry Age-Related Macular Degeneration Consumption Value by Application (2019-2024) & (USD Million)
Table 82. North America Dry Age-Related Macular Degeneration Consumption Value by Application (2025-2030) & (USD Million)
Table 83. North America Dry Age-Related Macular Degeneration Consumption Value by Country (2019-2024) & (USD Million)
Table 84. North America Dry Age-Related Macular Degeneration Consumption Value by Country (2025-2030) & (USD Million)
Table 85. Europe Dry Age-Related Macular Degeneration Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Europe Dry Age-Related Macular Degeneration Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Europe Dry Age-Related Macular Degeneration Consumption Value by Application (2019-2024) & (USD Million)
Table 88. Europe Dry Age-Related Macular Degeneration Consumption Value by Application (2025-2030) & (USD Million)
Table 89. Europe Dry Age-Related Macular Degeneration Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Dry Age-Related Macular Degeneration Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Dry Age-Related Macular Degeneration Consumption Value by Type (2019-2024) & (USD Million)
Table 92. Asia-Pacific Dry Age-Related Macular Degeneration Consumption Value by Type (2025-2030) & (USD Million)
Table 93. Asia-Pacific Dry Age-Related Macular Degeneration Consumption Value by Application (2019-2024) & (USD Million)
Table 94. Asia-Pacific Dry Age-Related Macular Degeneration Consumption Value by Application (2025-2030) & (USD Million)
Table 95. Asia-Pacific Dry Age-Related Macular Degeneration Consumption Value by Region (2019-2024) & (USD Million)
Table 96. Asia-Pacific Dry Age-Related Macular Degeneration Consumption Value by Region (2025-2030) & (USD Million)
Table 97. South America Dry Age-Related Macular Degeneration Consumption Value by Type (2019-2024) & (USD Million)
Table 98. South America Dry Age-Related Macular Degeneration Consumption Value by Type (2025-2030) & (USD Million)
Table 99. South America Dry Age-Related Macular Degeneration Consumption Value by Application (2019-2024) & (USD Million)
Table 100. South America Dry Age-Related Macular Degeneration Consumption Value by Application (2025-2030) & (USD Million)
Table 101. South America Dry Age-Related Macular Degeneration Consumption Value by Country (2019-2024) & (USD Million)
Table 102. South America Dry Age-Related Macular Degeneration Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Middle East & Africa Dry Age-Related Macular Degeneration Consumption Value by Type (2019-2024) & (USD Million)
Table 104. Middle East & Africa Dry Age-Related Macular Degeneration Consumption Value by Type (2025-2030) & (USD Million)
Table 105. Middle East & Africa Dry Age-Related Macular Degeneration Consumption Value by Application (2019-2024) & (USD Million)
Table 106. Middle East & Africa Dry Age-Related Macular Degeneration Consumption Value by Application (2025-2030) & (USD Million)
Table 107. Middle East & Africa Dry Age-Related Macular Degeneration Consumption Value by Country (2019-2024) & (USD Million)
Table 108. Middle East & Africa Dry Age-Related Macular Degeneration Consumption Value by Country (2025-2030) & (USD Million)
Table 109. Dry Age-Related Macular Degeneration Raw Material
Table 110. Key Suppliers of Dry Age-Related Macular Degeneration Raw Materials
List of Figures
Figure 1. Dry Age-Related Macular Degeneration Picture
Figure 2. Global Dry Age-Related Macular Degeneration Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Dry Age-Related Macular Degeneration Consumption Value Market Share by Type in 2023
Figure 4. Oral
Figure 5. Injectables
Figure 6. Global Dry Age-Related Macular Degeneration Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Dry Age-Related Macular Degeneration Consumption Value Market Share by Application in 2023
Figure 8. Above 40 Years Picture
Figure 9. Above 60 Years Picture
Figure 10. Above 75 Years Picture
Figure 11. Global Dry Age-Related Macular Degeneration Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Dry Age-Related Macular Degeneration Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Dry Age-Related Macular Degeneration Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Dry Age-Related Macular Degeneration Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Dry Age-Related Macular Degeneration Consumption Value Market Share by Region in 2023
Figure 16. North America Dry Age-Related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Dry Age-Related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Dry Age-Related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Dry Age-Related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Dry Age-Related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Dry Age-Related Macular Degeneration Revenue Share by Players in 2023
Figure 22. Dry Age-Related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Dry Age-Related Macular Degeneration Market Share in 2023
Figure 24. Global Top 6 Players Dry Age-Related Macular Degeneration Market Share in 2023
Figure 25. Global Dry Age-Related Macular Degeneration Consumption Value Share by Type (2019-2024)
Figure 26. Global Dry Age-Related Macular Degeneration Market Share Forecast by Type (2025-2030)
Figure 27. Global Dry Age-Related Macular Degeneration Consumption Value Share by Application (2019-2024)
Figure 28. Global Dry Age-Related Macular Degeneration Market Share Forecast by Application (2025-2030)
Figure 29. North America Dry Age-Related Macular Degeneration Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Dry Age-Related Macular Degeneration Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Dry Age-Related Macular Degeneration Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Dry Age-Related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Dry Age-Related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Dry Age-Related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Dry Age-Related Macular Degeneration Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Dry Age-Related Macular Degeneration Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Dry Age-Related Macular Degeneration Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Dry Age-Related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
Figure 39. France Dry Age-Related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Dry Age-Related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Dry Age-Related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Dry Age-Related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Dry Age-Related Macular Degeneration Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Dry Age-Related Macular Degeneration Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Dry Age-Related Macular Degeneration Consumption Value Market Share by Region (2019-2030)
Figure 46. China Dry Age-Related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Dry Age-Related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Dry Age-Related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
Figure 49. India Dry Age-Related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Dry Age-Related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Dry Age-Related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Dry Age-Related Macular Degeneration Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Dry Age-Related Macular Degeneration Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Dry Age-Related Macular Degeneration Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Dry Age-Related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Dry Age-Related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Dry Age-Related Macular Degeneration Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Dry Age-Related Macular Degeneration Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Dry Age-Related Macular Degeneration Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Dry Age-Related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Dry Age-Related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Dry Age-Related Macular Degeneration Consumption Value (2019-2030) & (USD Million)
Figure 63. Dry Age-Related Macular Degeneration Market Drivers
Figure 64. Dry Age-Related Macular Degeneration Market Restraints
Figure 65. Dry Age-Related Macular Degeneration Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Dry Age-Related Macular Degeneration in 2023
Figure 68. Manufacturing Process Analysis of Dry Age-Related Macular Degeneration
Figure 69. Dry Age-Related Macular Degeneration Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Santen Pharmaceuticals Allergan Bausch Health Alimera Science Phio Pharmaceuticals Ocumension Therapeutics Belite Bio Kubota Vision Iveric Bio Eyestem Research Y2 Solution Stealth Biotherapeutics
Related Reports
23 Jan 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
